Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Seraprevir in Combination With Sofosbuvir in Patients With Chronic Genotype 1 Hepatitis C Virus Infection.

NCT04001608 is registered in ClinicalTrials.gov with Ginkgopharma CO., LTD as lead sponsor.

NCT NCT04001608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04001608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Seraprevir in Combination With Sofosbuvir in Patients With Chronic Genotype 1 Hepatitis C Virus Infection.
Lead sponsor
Ginkgopharma CO., LTD
Phase
Phase 3
Overall status
Unknown status
Start date
October 17, 2018
Completion date
November 30, 2019
Enrollment
206 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection